SCHEMBL29979013

SCHEMBL29979013

CN(C)S(=O)(=O)c1ccc(S(=O)(=O)Nc2ccccc2-c2cccnc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.53
LMNA P02545 2/20 0.53
MCOLN3 Q8TDD5 2/20 0.53
CA12 O43570 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
CKS1B P61024 4/20 0.51
SKP2 Q13309 4/20 0.51
PTGS2 P35354 1/20 0.50
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
USP2 O75604 1/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
NOD2 Q9HC29 1/20 0.48
KCNA5 P22460 2/20 0.47
BDKRB1 P46663 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23057275 1.00 NAMPT (0.53) NAMPTLMNAMCOLN3CA12CA2
SCHEMBL23057287 0.86 LMNA (0.71) LMNAMCOLN3CA12CA2CA9
SCHEMBL28402292 0.86 NAMPT (0.60) NAMPTLMNAMCOLN3CA12CA2
SCHEMBL31720637 0.77 KCNA5 (0.56) NAMPTLMNAALDH1A1KDM4EKCNA5
SCHEMBL28455396 0.77 SLC22A12 (0.67) NAMPTCKS1BSKP2PTGS2ALDH1A1
SCHEMBL30936619 0.73 MCOLN2 (0.51) LMNAALDH1A1L3MBTL1USP2POLB
SCHEMBL7370367 0.73 CKS1B (0.53) NAMPTLMNAMCOLN3CA12CA2
SCHEMBL6691608 0.72 MEN1 (0.52) NAMPTCA12CA2CA9CKS1B
SCHEMBL23043640 0.72 MCOLN2 (0.50) LMNACA2CA9ALDH1A1L3MBTL1
SCHEMBL23057210 0.72 KEAP1 (0.51) LMNAALDH1A1L3MBTL1USP2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 NAMPT 877/4885LMNA 581/4885MCOLN3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.